GREEN BROAD (01253) enters into a share exchange agreement with Greenland Financial
Green Broad (01253) and Greenland Financial Overseas Investment Group Co., Ltd. jointly announce that the share exchange agreement is intended to, among other things, reduce the Company's overall offshore debt level by approximately 52%.
GREEN BROAD (01253) and Greenland Financial Overseas Investment Group Co., Ltd. jointly announce that the share exchange agreement is intended to, among other things, reduce the Company's overall offshore debt level by approximately 52%.
As at 31 May 2026, the Group had outstanding debt (including accrued interest) owed to Greenland Financial in the amount of approximately HK$155 million. On 21 September 2026 (after trading hours), the Company and Greenland Financial entered into the share exchange agreement, pursuant to which the Company agreed to allot and issue 595 million exchange shares to Greenland Financial at an issue price of HK$0.26 per exchange share, in full settlement of the outstanding debt. As at the date of this joint announcement, save for the outstanding debt and approximately RMB81 million of interest-free financial assistance provided by Greenland (with no fixed repayment schedule, for the purpose of supporting the Company's general working capital), the Company has no other debts or liabilities owed to Greenland or any of its subsidiaries.
The 595 million exchange shares represent approximately 98.51% of the total number of issued shares of the Company as at the date of this joint announcement; and approximately 49.62% of the total number of issued shares of the Company as enlarged by the allotment and issue of the exchange shares.
Related Articles

CU VENTURE INV (08159) proposes a share consolidation on a "20-into-1" basis.

US Stock Market Move | Optical communication stocks rise; Astera Labs (ALAB.US) gains over 7%.

LEADS BIOLABS-B(09887): Vilxin (opamtisumab, PD-L1/41BB bispecific antibody) monotherapy for advanced EP-NEC pivotal registrational Phase IIB study selected as LBA, and three studies granted preferred oral presentation eligibility
CU VENTURE INV (08159) proposes a share consolidation on a "20-into-1" basis.

US Stock Market Move | Optical communication stocks rise; Astera Labs (ALAB.US) gains over 7%.

LEADS BIOLABS-B(09887): Vilxin (opamtisumab, PD-L1/41BB bispecific antibody) monotherapy for advanced EP-NEC pivotal registrational Phase IIB study selected as LBA, and three studies granted preferred oral presentation eligibility

RECOMMEND





